Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands

Histopathology

Volumn 61, Issue 3, 2012, Pages 387-394

  Chiosea, Simion I ^a   Griffith, Christopher ^a   Assaad, Adel ^b   Seethala, Raja R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Acinic cell carcinoma; ETV6; Mammary analogue secretory carcinoma

Indexed keywords

MUCIN; TRANSCRIPTION FACTOR ETV6;

ACINAR CELL CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY ANALOGUE SECRETORY CARCINOMA; NECK DISSECTION; PAROTID GLAND; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA;

ADULT; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; SALIVARY GLAND NEOPLASMS;

EID: 84865391683     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04232.x     Document Type: Article

References (26)

1. Skalova A, Vanecek T, Sima R et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am. J. Surg. Pathol. 2010; 34; 599-608.
2. Tognon C, Knezevich SR, Huntsman D et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002; 2; 367-376.
3. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat. Genet. 1998; 18; 184-187.
4. Knezevich SR, Garnett MJ, Pysher TJ, Beckwith JB, Grundy PE, Sorensen PH. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998; 58; 5046-5048.
5. Eguchi M, Eguchi-Ishimae M, Tojo A et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 1999; 93; 1355-1363.
6. Griffith C, Seethala R, Chiosea SI. Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma. Virchows Arch. 2011; 459; 117-118.
7. Fehr A, Loning T, Stenman G. Mammary analogue secretory carcinoma of the salivary glands with ETV6-NTRK3 gene fusion. Am. J. Surg. Pathol. 2011; 35; 1600-1602.
8. Connor A, Perez-Ordonez B, Shago M, Skalova A, Weinreb I. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am. J. Surg. Pathol. 2012; 36 (1); 27-34.
9. Yu L, Chiosea SI. Re-evaluating historic cohort of salivary acinic cell carcinoma with new diagnostic tools. Head Neck Pathol. 2011; [Epub ahead of print] DOI: 10.1007/s12105-011-0312-9.
10. Petersson F, Lian D, Chau YP, Yan B. Mammary analogue secretory carcinoma: the first submandibular case reported including findings on fine needle aspiration cytology. Head Neck Pathol. 2011; [Epub ahead of print] DOI: 10.1007/s12105-011-0283-x.
11. Chiosea SI, Griffith C, Assaad A, Seethala RR. The profile of acinic cell carcinoma after recognition of mammary analogue secretory carcinoma. Am. J. Surg. Pathol. 2012; [Epub ahead of print] DOI: 10.1097/PAS.0b013e318242a5b0.
12. Chiosea SI, Peel R, Barnes EL, Seethala RR. Salivary type tumors seen in consultation. Virchows Arch. 2009; 454; 457-466.
13. Seethala RR, Johnson JT, Barnes EL, Myers EN. Polymorphous low-grade adenocarcinoma: the University of Pittsburgh experience. Arch. Otolaryngol. Head Neck Surg. 2010; 136; 385-392.
14. Chenevert J, Barnes LE, Chiosea SI. Mucoepidermoid carcinoma: a five-decade journey. Virchows Arch. 2011; 458; 133-140.
15. Chiosea SI, Barnes EL, Lai SY et al. Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression. Virchows Arch. 2008; 452; 629-635.
16. Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Am. J. Surg. Pathol. 2010; 34; 1106-1121.
17. Chiosea SI, Nikiforova MN, Dacic S, Seethala RR. Prospective testing of mucoepidermoid carcinoma for the MAML2 translocation: clinical implications. Laryngoscope (in press).
18. Hirokawa M, Sugihara K, Sai T et al. Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma? Histopathology 2002; 40; 223-239.
19. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual, 7th edn. New York: Springer, 2010.
20. Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am. J. Surg. Pathol. 2007; 31; 44-57.
21. Ghannoum JE, Freedman PD. Signet-ring cell (mucin-producing) adenocarcinomas of minor salivary glands. Am. J. Surg. Pathol. 2004; 28; 89-93.
22. Wlodarska I, Mecucci C, Baens M, Marynen P, van den Berghe H. ETV6 gene rearrangements in hematopoietic malignant disorders. Leuk. Lymph. 1996; 23; 287-295.
23. Walz C, Erben P, Ritter M et al. Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3. Blood 2011; 118; 2239-2242.
24. Jabber Al-Obaidi MS, Martineau M, Bennett CF et al. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia 2002; 16; 669-674.
25. O'Brien SG, Vieira SA, Connors S et al. Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation. Blood 2002; 99; 3465-3467.
26. Tognon CE, Somasiri AM, Evdokimova VE et al. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway. Cancer Res. 2011; 71; 1060-1070.